pfizer News of 11/28/20
AstraZeneca Says It Will Likely Do Another Study Of COVID-19 Vaccine After Accidental Lower Dose Shows Higher Efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase 3 ...
Oxford University’S COVID-19 Vaccine Shows High Efficacy, And Is Cheaper To Make And Easier To Store
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different ...
Pfizer And BioNTech To Submit Request For Emergency Use Approval Of Their COVID-19 Vaccine Today
Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today. ...
Pfizer Says Its COVID-19 Vaccine Is 95% Effective In Final Clinical Trial Results Analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. ...
Moderna Reports Its COVID-19 Vaccine Is 94.5% Effective In First Data From Phase 3 Trial
Following fast on the heels of Pfizer’s announcement of its COVID-19 vaccine efficacy, Moderna is also sharing positive results from its Phase 3 trial on Monday. The biotech company says that its COVID-19 vaccine candidate has shown efficacy ...
Carbon Health Raises $100 Million With Plans To Expand Pop-Up Clinics Ahead Of COVID-19 Vaccination Programs
Carbon Health has raised a $100 million Series C funding round, led by Dragoneer Investment Group and including participation from prior investors Brookfield Technology Partners, DCVC and Builders VC. This funding will be used to help the SF-based ...
Pfizer’S COVID-19 Vaccine Proves 90% Effective In First Results From Phase 3 Clinical Trial
The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announce d on Monday. That’s based on data analyzed ...
The US Now Seems To Be Pinning All Of Its Hopes On COVID-19 Therapies And Vaccines
Almost eight months after the White House first announced it would move from containment to mitigation efforts to stop the spread of the COVID-19 epidemic, the Administration is now pinning its hopes on vaccines to inoculate the population and ...
Pfizer And BioNTech Announce Joint Development Of A Potential COVID-19 Vaccine
Pharma giant Pfizer announced on Tuesday that it’s working with BioNTech, a German company working on new kinds of immunotherapy treatments, on a potential COVID-19 vaccine. The joint effort, confirmed Tuesday via a signed letter of intent, ...
All That Glitters Is Not Gold: How Healthtech Startups Can Achieve True Value
Eli Cahan Contributor Share on Twitter Eli Cahan is a medical student at NYU on leave to complete a master’s in health policy at Stanford as a Knight-Hennessey Scholar. His research addresses the ...
Drone Delivery Startup Zipline Launches UAV Medical Program In Ghana
Zipline , the San Francisco-based UAV manufacturer and logistics services provider, has launched a program in Ghana today for drone delivery of medical supplies. Working with the Ghanaian government, Zipline will operate 30 drones out of four ...